Medivir AB has exclusively licenced Greater China development and commercialisation rights of its preclinical...
Up To Date
Latest News
Using a national supercomputer, Swedish researchers have analysed how protein expression of the 315 known...
Finnish Metsä Group has started its mill for bio-based products. The €1.2bn investment’s production capacity...
UK-headquartered immunodiagnostics specialist Oxford Immunotec Global plc's share value slipped by $1.31 to...
German CellAct GmbH has cashed in US$250m (€212m) from Mundipharma in a licence deal for CAP7.1, a Phase II...
Germany is the first country that has granted full approval to Adrenomed to conduct a Phase II study with the...
Share
